Eisai to Present Latest Data on Lemborexant at The 36th Annual Sleep 2022 Meeting

TOKYO, June 3, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced a total of seven poster presentations including the latest data on its in-house discovered orexin receptor antagonist lemborexant (product

Related Keywords

Japan ,Tokyo ,United States ,Ivan Cheung ,Eisai Co Ltd ,Neurology Business Group ,Eisai Inc ,Associated Professional Sleep Societies ,Senior Vice President ,President Neurology Business Group ,Clin Sleep ,Eisai ,Present ,Latest ,Data ,Lemborexant ,6th ,Nnual ,Sleep ,022 ,Meeting ,